Cargando…
Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review
AIMS: With a prevalence of 16%, diabetes mellitus (DM) is one of the most frequent non‐communicable comorbidities of tuberculosis (TB). DM is a major risk factor for adverse TB outcomes and may require personalized TB drug dosing regimens. However, information on the inclusion of DM in TB drug trial...
Autores principales: | Lutfiana, Nurul Cholifah, van Boven, Job F.M., Masoom Zubair, Muhammad Asim, Pena, Michelle J., Alffenaar, Jan‐Willem C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595305/ https://www.ncbi.nlm.nih.gov/pubmed/30908689 http://dx.doi.org/10.1111/bcp.13935 |
Ejemplares similares
-
Sleep-Disordered Breathing and Gestational Diabetes Mellitus: A meta-analysis of 9,795 participants enrolled in epidemiological observational studies
por: Luque-Fernandez, Miguel Angel, et al.
Publicado: (2013) -
Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
por: Patel, Parita, et al.
Publicado: (2020) -
Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis
por: Kotha, Sreelakshmi, et al.
Publicado: (2021) -
Nutritional and exercise interventions in individuals with sarcopenic obesity
around retirement age: a systematic review and meta-analysis
por: Eglseer, Doris, et al.
Publicado: (2023) -
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach
por: Purnomo, Athaya Febriantyo, et al.
Publicado: (2023)